Strides Pharma Science informs about outcome of board meeting

09 Jan 2020 Evaluate

Strides Pharma Science has informed that the Board of Directors of the Company in their meeting held on 8-01-2020 have approved the appointment of R Ananthanarayanan (DIN: 02231540) as Chief Executive Officer & Managing Director of the Company effective January 9, 2020, for a period of 5 years, subject to approval of the Members of the Company. Further, he is also appointed as Key Managerial Personnel of the Company effective January 9, 2020. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said appointment is enclosed as Annexure. The Company also approved re-designation of Arun Kumar (DIN: 00084845) as Executive Director effective January 9, 2020.

The above information is a part of company’s filings submitted to BSE.




Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×